Literature DB >> 26321606

False Increase of Estradiol Levels in a 36-Year-Old Postmenopausal Patient With Estrogen Receptor-Positive Breast Cancer Treated With Fulvestrant.

Daniel Berger1, Salman Waheed2, Yacob Fattout3, Rasa Kazlauskaite3, Lydia Usha2.   

Abstract

Entities:  

Keywords:  False positive; Hormone receptor-positive breast cancer; Immunoassay; Laboratory error; Metastatic breast cancer

Mesh：

Substances：

Year:  2015        PMID： 26321606     DOI： 10.1016/j.clbc.2015.07.004

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN： 1526-8209            Impact factor:   3.225


× No keyword cloud information.
  2 in total

1.  Fulvestrant May Falsely Increase 17β-Estradiol Levels in Immunoassays: A Case Report of a 57-Year-Old Postmenopausal Patient With Recurrent Estrogen Receptor-Positive Breast Cancer.

Authors:  Jingxian Ding; Yali Cao; Yonghong Guo
Journal:  Front Oncol       Date:  2022-04-13       Impact factor: 5.738

2.  Oestradiol measurement during fulvestrant treatment for breast cancer.

Authors:  Laura J Owen; Phillip J Monaghan; Anne Armstrong; Brian G Keevil; Claire Higham; Zena Salih; Sacha Howell
Journal:  Br J Cancer       Date:  2019-01-25       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.